日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Efficacy and Safety of Daridorexant in Older and Younger Adults with Insomnia Disorder: A Secondary Analysis of a Randomised Placebo-Controlled Trial

Daridorexant治疗老年和年轻失眠症患者的疗效和安全性：一项随机安慰剂对照试验的二次分析

期刊:Drugs & Aging
影响因子:3.8
doi:10.1007/s40266-022-00977-4
Fietze, Ingo; Bassetti, Claudio L A; Mayleben, David W; Pain, Scott; Seboek Kinter, Dalma; McCall, William V
发表日期：2022
文献求助 收藏

Comparison of the effect of lemborexant with placebo and zolpidem tartrate extended release on sleep architecture in older adults with insomnia disorder

比较伦博雷生与安慰剂和酒石酸唑吡坦缓释片对老年失眠症患者睡眠结构的影响

期刊:Journal of Clinical Sleep Medicine
影响因子:2.9
doi:10.5664/jcsm.9150
Moline, Margaret; Zammit, Gary; Cheng, Jocelyn Y; Perdomo, Carlos; Kumar, Dinesh; Mayleben, David
发表日期：2021
文献求助 收藏

Assessment of morning sleep propensity with lemborexant in adults with insomnia disorder in a randomized, placebo-controlled crossover study

在一项随机、安慰剂对照交叉研究中评估伦博雷生对失眠症成年患者晨间睡眠倾向的影响

期刊:Sleep Advances
影响因子:
doi:10.1093/sleepadvances/zpab011
Mayleben, David; Rosenberg, Russell; Pinner, Kate; Hussein, Ziad; Moline, Margaret
发表日期：2021
文献求助 收藏

Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder: A Phase 3 Randomized Clinical Trial

比较 Lemborexant 与安慰剂和酒石酸唑吡坦缓释片治疗老年失眠症患者的疗效：一项 3 期随机临床试验

期刊:Jama Network Open
影响因子:9.7
doi:10.1001/jamanetworkopen.2019.18254
Rosenberg, Russell; Murphy, Patricia; Zammit, Gary; Mayleben, David; Kumar, Dinesh; Dhadda, Shobha; Filippov, Gleb; LoPresti, Antonia; Moline, Margaret
发表日期：2019
文献求助 收藏

A novel forehead temperature-regulating device for insomnia: a randomized clinical trial

一种用于治疗失眠的新型额温调节装置：一项随机临床试验

期刊:Sleep
影响因子:4.9
doi:10.1093/sleep/zsy045
Roth, Thomas; Mayleben, David; Feldman, Neil; Lankford, Alan; Grant, Timothy; Nofzinger, Eric
发表日期：2018
文献求助 收藏

Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study

Lemborexant，一种用于治疗失眠症的双重食欲素受体拮抗剂（DORA）：一项贝叶斯、自适应、随机、双盲、安慰剂对照研究的结果

期刊:Journal of Clinical Sleep Medicine
影响因子:2.9
doi:10.5664/jcsm.6800
Murphy, Patricia; Moline, Margaret; Mayleben, David; Rosenberg, Russell; Zammit, Gary; Pinner, Kate; Dhadda, Shobha; Hong, Quan; Giorgi, Luigi; Satlin, Andrew
信号转导
发表日期：2017
文献求助 收藏

A randomized, double-blind, single-dose, placebo-controlled, multicenter, polysomnographic study of gabapentin in transient insomnia induced by sleep phase advance

一项随机、双盲、单剂量、安慰剂对照、多中心、多导睡眠图研究，旨在评估加巴喷丁治疗睡眠相位提前引起的短暂性失眠的疗效。

期刊:Journal of Clinical Sleep Medicine
影响因子:2.9
doi:10.5664/jcsm.4108
Rosenberg, Russell P; Hull, Steven G; Lankford, D Alan; Mayleben, David W; Seiden, David J; Furey, Sandy A; Jayawardena, Shyamalie; Roth, Thomas
发表日期：2014
文献求助 收藏

Daytime pharmacodynamic and pharmacokinetic evaluation of low-dose sublingual transmucosal zolpidem hemitartrate

日间药效学和药代动力学评价低剂量舌下黏膜给药唑吡坦酒石酸盐

期刊:Human Psychopharmacology-Clinical and Experimental
影响因子:1.7
doi:10.1002/hup.884
Roth, Thomas; Mayleben, David; Corser, Bruce C; Singh, Nikhilesh N
发表日期：2008
文献求助 收藏